Key Takeaways
- Nike’s fiscal third-quarter earnings arrive March 31, with analysts projecting $11.2B in revenue and $0.28 earnings per share—half of last year’s $0.54.
- Shares trade at $51.37, barely above the 52-week low, having tumbled 25% in six months and 19% since January.
- Goldman Sachs maintains a Buy rating with a $76 target, arguing that current valuations already account for near-term turbulence.
- Investor attention centers on China’s consumer recovery, gross margin performance, and leadership’s vision for product development.
- The options market is anticipating a 9% swing in either direction once earnings are released.
The athletic apparel giant is scheduled to unveil fiscal third-quarter financials after market close on March 31. Consensus calls for revenue to reach $11.2B with earnings per share landing at $0.28—significantly below the $0.54 posted during the comparable quarter a year earlier.
Shares have faced sustained selling pressure entering this report. The stock has shed 25% over the trailing six-month period and dropped 19% year-to-date, currently hovering just above its 52-week bottom of $51.20.
Implied volatility suggests investors are bracing for a 9% post-earnings move in either direction. That elevated expectation underscores the uncertainty surrounding the company’s trajectory.
Goldman Sachs reaffirmed its Buy recommendation with a $76 price objective over the weekend. The investment bank acknowledged Nike remains among the most contentious names it covers, though debate has subsided somewhat amid broader economic uncertainty.
The firm characterized third-quarter indicators as inconclusive. While China search trends and point-of-sale data have shown sequential improvement, absolute levels remain subdued with no definitive growth catalyst visible. Domestic brand metrics paint a similarly ambiguous picture—interest in core product lines is strengthening, but new launch engagement and promotional intensity continue to disappoint.
Goldman expressed confidence that prevailing estimates already incorporate short-term obstacles and that the company’s “Win Now” initiative positions the brand favorably heading into fiscal 2027.
Wall Street Perspectives Diverge
Oppenheimer analyst Brian Nagel doesn’t anticipate a comprehensive resolution in this report, yet he contends the market narrative surrounding Nike’s difficulties obscures genuine operational improvements. He maintains the stock as a preferred holding, arguing its “historically depressed valuation multiples” fail to reflect the long-term turnaround potential.
BTIG analyst Robert Drbul takes a more assertive stance. He believes management is executing strategic pivots with greater speed and conviction than investors recognize—citing workforce reductions at Converse, logistics restructuring in Memphis, and recent executive appointments as evidence of purposeful transformation.
Jefferies holds a Buy rating with a $110 price target and highlighted North America as an encouraging market, where growth approached 9% in the previous quarter. Piper Sandler takes a more conservative view at $75, pointing to murky visibility on China’s rebound and sluggish performance in the running segment.
Evercore ISI reduced its price objective to $69 from $77, simultaneously lowering its fiscal 2027 earnings estimate to $2.00 from $2.30. Telsey Advisory Group also cut its target to $65 from $72, emphasizing margin compression.
China Recovery Remains Central Question
The company’s China commentary will resonate beyond Nike’s own investor base. Starbucks (SBUX), Estee Lauder (EL), and Skechers (SKX) represent other companies where investors will parse comparable signals about consumer health in the region.
On Holdings (ONON) exhibits the strongest trading correlation with Nike over the past year, positioning it as another stock likely to react to Nike’s results.
Nike has increased its dividend for 24 straight years and presently offers a 3.19% yield.
Earnings will be released after the closing bell on March 31.
